Gabriella Fabbrocini
Overview
Explore the profile of Gabriella Fabbrocini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
621
Citations
5232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Starace M, Mandel V, Ardigo M, Carpanese M, Quadrelli F, Pampaloni F, et al.
Dermatol Ther (Heidelb)
. 2025 Mar;
PMID: 40064753
Introduction: Literature about trichoscopy of permanent chemotherapy-induced alopecia (pCIA) is still scarce, while no data were published regarding reflectance confocal microscopy (RCM). The aim of our study is to monitor...
2.
Campanati A, Esposito M, Caldarola G, Cacciapuoti S, Fabbrocini G
Drugs Context
. 2024 Oct;
13.
PMID: 39416771
A fixed-dose combination of calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD) aerosol foam (Enstilar, LEO Pharma) is the only topical therapy approved for the acute (reactive) and proactive management of psoriasis. Although...
3.
Offidani A, Marzano A, Peris K, Molinelli E, Bettoli V, Magnoni C, et al.
Dermatology
. 2024 Jul;
240(5-6):885-896.
PMID: 39004081
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent and painful nodules and abscesses in intertriginous skin areas, which can progress to sinus tract formation, tissue destruction,...
4.
Prignano F, Atzori L, Bellinato F, Damiani G, Galeone C, Mariani P, et al.
Dermatology
. 2024 Mar;
240(3):414-424.
PMID: 38493762
Introduction: Generalized pustular psoriasis (GPP) is a rare and chronic, debilitating skin condition characterized, in its acute flare phase, by clinically severe and potentially life-threatening systemic manifestations. Data on GPP...
5.
Picone V, Martora F, De Fata Salvatores G, Spennato S, Gallo L, Fabbrocini G
Ital J Dermatol Venerol
. 2024 Feb;
159(2):196-197.
PMID: 38305081
No abstract available.
6.
Patruno C, Fabbrocini G, Napolitano M
Ital J Dermatol Venerol
. 2024 Jan;
159(1):60-61.
PMID: 38261308
No abstract available.
7.
Prignano F, Argenziano G, Bardazzi F, Borroni R, Brunasso A, Burlando M, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202108
A nationwide cross-sectional online survey was administered to dermatologists managing patients with moderate-to-severe plaque psoriasis across Italy to obtain real-world dermatologists' perspectives on the impact of psoriasis and its treatment...
8.
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, et al.
Clin Cosmet Investig Dermatol
. 2023 Dec;
16:3561-3574.
PMID: 38107670
Purpose: SUPREME, a phase IIIb study conducted in Italy, demonstrated safety and high efficacy of secukinumab for up to 72 weeks in patients with moderate-to-severe plaque-type psoriasis. SUPREME 2.0 study...
9.
Napolitano M, Genco L, Noto M, Fabbrocini G, Patruno C
J Cosmet Dermatol
. 2023 Nov;
23(2):714-716.
PMID: 37950426
No abstract available.
10.
Stingeni L, Chiricozzi A, Calzavara-Pinton P, Napolitano M, Peris K, Schena D, et al.
Am J Clin Dermatol
. 2023 Nov;
25(1):161.
PMID: 37934365
No abstract available.